MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0052138
HCG Nchri Oncology LLP
HCG Nchri Oncology LLP - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹90.03 Cr
▲ 25% YoY
Net profit · FY 2025
₹17.02 Cr
Net margin 18.9%
EBITDA · FY 2025
₹12.3 Cr
EBITDA margin 13.7%
Contribution obligation
₹173.06 Cr
As per LLP agreement
Open charges
₹36 Cr
Satisfied ₹100 Cr
LLP age
12 yrs
Est. 2014
Employees · EPFO
192
Provident fund records
Designated partners
2
As per MCA filings
About HCG Nchri Oncology LLP
Data last updated:
HCG Nchri Oncology LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 03 September 2014 and has been in existence for over 12 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAC-6655. Its GSTIN is 27AAIFH2349P2ZT (Maharashtra). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹173.06 Cr. It is led by designated partners Srinivasa Venkatavaradhan Raghavan and Manish Mattoo.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the LLP reported a revenue of ₹90.03 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹17.02 Cr (net margin 18.9%) and EBITDA of ₹12.3 Cr (EBITDA margin 13.7%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 48% over five years.
The LLP has about 192 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹36 Cr and satisfied charges of ₹100 Cr on record.
HCG Nchri Oncology LLP is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0052138).
Company details
LLPIN AAC-6655
Incorporation Date 03 September 2014
Total Obligation of Contribution ₹173.06 Cr
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2026
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0052138
Recognitions & Rankings of HCG Nchri Oncology
Contact details
HCG Nchri Oncology LLP's registered office is in Bangalore, Karnataka.
- Registered AddressHcg Tower No. 8.P. Kalinga Rao Road Sampangi Rama, Nagar, Bangalore, Karnataka, India – 560027
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
Comprehensive company report
HCG Nchri Oncology LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of HCG Nchri Oncology LLP
FY 2025 filings availableHCG Nchri Oncology LLP reported revenue of ₹90.03 Cr (up 25% YoY) for FY 2025.
Revenue · FY 2025
₹90.03 Cr ▲ 25%
Net profit · FY 2025
₹17.02 Cr margin 18.9%
EBITDA · FY 2025
₹12.3 Cr margin 13.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 23%
5 years · compounded
▲ 48%
EBITDA CAGR growth
1 year
▲ 166%
3 years · compounded
▲ 115%
Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 25% growth in the latest year. EBITDA rose 166% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹90.03 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹17.02 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 18.9% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of HCG Nchri Oncology LLP, buy the company report.
Designated partners of HCG Nchri Oncology LLP
HCG Nchri Oncology has 2 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Venkatavaradhan Raghavan Also directs: HCG Oncology Hospitals LLP, HCG Manavata Oncology LLP, Bacc Health Care Private Limited and 2 more | Designated Partner | 24 Aug 2019 | 7 Years 2 Months | Current |
| Manish Mattoo Also directs: Suchirayu Health Care Solutions Limited, Healthcare Diwan Chand Imaging LLP, HCG Oncology LLP and 5 more | Designated Partner | 30 Jun 2025 | 1 Years 3 Months | Current |
Charges & borrowings
Open charges
₹36 Cr
Satisfied charges
₹100 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 May 2016 | 100034196 | Yes Bank Limited | ₹36 Cr | Open | |
| 26 Dec 2024 | 101032262 | Icici Bank Limited | ₹100 Cr | Satisfied |
To see the full charge records of HCG Nchri Oncology LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving HCG Nchri Oncology LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
HCG Nchri Oncology LLP was last rated by Icra on 22 Dec 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 22 Dec 2022 |
To see the full credit ratings and regulatory alerts of HCG Nchri Oncology LLP, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HCG Nchri Oncology LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
HCG Nchri Oncology LLP has a workforce of 192 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
192
Active EPFO establishments
1
Employee growth
9.71%
GST
HCG Nchri Oncology has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAIFH2349P2ZT | Maharashtra | Active | 17 Aug 2017 |
To see the full GST registrations and return filing status of HCG Nchri Oncology LLP, buy the company report.
Recent activity
HCG Nchri Oncology LLP has 7 designated partner changes on record since 2016: 3 appointments and 4 cessations. The latest: Manish Mattoo was appointed as Designated Partner on 30 Jun 2025.
Charges
A charge registered on 26 Dec 2024 via Charge ID 101032262 with Icici Bank Limited was fully satisfied on 16 Apr 2026.
AGM
Hcg Nchri Oncology Llp last Annual general meeting of members was held on 31 Mar 2026 as per latest MCA records.
Appointed
Manish Mattoo was appointed as Designated Partner.
Filing
Hcg Nchri Oncology Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Icici Bank Limited amounted to Rs. 100.00 Cr with Charge ID 101032262 was registered on 26 Dec 2024.
Appointed
Meghraj Arvindrao Gore was appointed as Designated Partner.
Ceased
Suchitra Ajay Mehta ceased to be Designated Partner.
Ceased
Ajay Mehta Omprakash ceased to be Designated Partner.
Appointed
Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner.
Ceased
Dinesh Madhavan ceased to be Designated Partner.
Charges
A charge with Yes Bank Limited of Rs. 36.00 Cr registered on 10 May 2016 with Charge ID 100034196 was modified on 10 Jun 2017.
Charges
A charge with Yes Bank Limited amounted to Rs. 36.00 Cr with Charge ID 100034196 was registered on 10 May 2016.
2 earlier events are in the company report.
Frequently asked questions
HCG Nchri Oncology is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 03 September 2014 (12+ years old) and is registered under LLPIN AAC-6655.
HCG Nchri Oncology has 2 current designated partners:
- Srinivasa Venkatavaradhan Raghavan - Designated Partner
- Manish Mattoo - Designated Partner
The latest financial statements of HCG Nchri Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of HCG Nchri Oncology is 27AAIFH2349P2ZT, registered in Maharashtra. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of HCG Nchri Oncology is AAC-6655. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
HCG Nchri Oncology was incorporated on 03 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Manish Mattoo was appointed as Designated Partner on 30 Jun 2025. Meghraj Arvindrao Gore was appointed as Designated Partner on 22 Aug 2023. Suchitra Ajay Mehta ceased to be Designated Partner on 21 Aug 2023. HCG Nchri Oncology has 7 designated partner changes on record in total.
Yes, HCG Nchri Oncology is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0052138).
The registered office of HCG Nchri Oncology is at Hcg Tower No. 8.P. Kalinga Rao Road Sampangi Rama, Nagar, Bangalore, Karnataka, India – 560027.
HCG Nchri Oncology operates in the healthcare industry, in the oncology clinics and cancer treatment segment.